LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Publisher: BioMed Central
Journal: BMC Proceedings
Types: Article
Subjects: qv_38, Proceedings, wc_680, RA0421, wa_110, wa_530

Classified by OpenAIRE into

mesheuropmc: congenital, hereditary, and neonatal diseases and abnormalities
Achieving the 2020 goals for Neglected Tropical Diseases (NTDs) requires scale-up of Mass Drug Administration (MDA) which will require long-term commitment of national and global financing partners, strengthening national capacity and, at the community level, systems to monitor and evaluate activities and impact.\ud \ud For some settings and diseases, MDA is not appropriate and alternative interventions are required. Operational research is necessary to identify how existing MDA networks can deliver this more complex range of interventions equitably.\ud \ud The final stages of the different global programmes to eliminate NTDs require eliminating foci of transmission which are likely to persist in complex and remote rural settings. Operational research is required to identify how current tools and practices might be adapted to locate and eliminate these hard-to-reach foci.\ud \ud Chronic disabilities caused by NTDs will persist after transmission of pathogens ceases. Development and delivery of sustainable services to reduce the NTD-related disability is an urgent public health priority.\ud \ud LSTM and its partners are world leaders in developing and delivering interventions to control vector-borne NTDs and malaria, particularly in hard-to-reach settings in Africa. Our experience, partnerships and research capacity allows us to serve as a hub for developing, supporting, monitoring and evaluating global programmes to eliminate NTDs.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. WHO: Progress report 2000-2009 and strategic plan 2010-2020 of the global programme to eliminate lymphatic filariasis: halfway towards eliminating lymphatic filariasis. WHO: Geneva; 2010.
    • 2. WHO: Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation. WHO: Geneva; 2012.
    • 3. WHO: Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report on neglected tropical diseases: summary. World Health Organization,: Geneva; 2013.
    • 4. Rebollo M P, Bockarie M J: Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame. Expert Rev Anti Infect Ther 2013, 11(7):723-31.
    • 5. Rollinson D, et al: Time to set the agenda for schistosomiasis elimination. Acta tropica 2013, 128(2):423-440.
    • 6. Taylor M J, Hoerauf A, Bockarie M: Lymphatic filariasis and onchocerciasis. Lancet 2010, 376(9747):1175-85.
    • 7. Wanji S, et al: Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon. Parasit Vectors 2009, 2(1):39.
    • 8. Williams D, et al: The Global Snake Bite Initiative: an antidote for snake bite. The lancet 2010, 375(9708):89-91.
    • 9. Reimer L J, et al: Fit for purpose: do we have the right tools to sustain NTD elimination? 2014.
    • 10. Njelesani J, et al: A Systematic Approach to Capacity Strengthening of Laboratory Systems for Control of Neglected Tropical Diseases in Ghana, Kenya, Malawi and Sri Lanka. PLoS Negl Trop Dis 2014, 8(3):e2736.
    • 11. van den Berg H, Kelly-Hope L A, Lindsay S W: Malaria and lymphatic filariasis: the case for integrated vector management. The Lancet infectious diseases 2013, 13(1):89-94.
    • 12. Kelly-Hope L A, Molyneux D H, Bockarie M J: Can malaria vector control accelerate the interruption of lymphatic filariasis transmission in Africa; capturing a window of opportunity. Parasit Vectors 2013, 6:39.
    • 13. Reimer L J, et al: Insecticidal bed nets and filariasis transmission in Papua New Guinea. New England Journal of Medicine 2013, 369(8):745-753.
    • 14. GutiĆ©rrez J M, et al: The Need for Full Integration of Snakebite Envenoming within a Global Strategy to Combat the Neglected Tropical Diseases: The Way Forward. PLoS Negl Trop Dis 2013, 7(6):e2162.
    • 15. Gyapong J O, et al: Integration of control of neglected tropical diseases into health-care systems: challenges and opportunities. The Lancet 2010, 375(9709):160-165.
    • 16. Brantus P: Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis. Ann Trop Med Parasitol 2009, 103(Suppl 1):S5-10.
    • 17. Stanton M C, Bockarie M J, Kelly-Hope L A: Geographical Factors Affecting Bed Net Ownership, a Tool for the Elimination of Anopheles-Transmitted Lymphatic Filariasis in Hard-to-Reach Communities. PloS one 2013, 8(1): e53755.
    • 18. Stanton M C, et al: Baseline drivers of lymphatic filariasis in Burkina Faso. Geospatial health 2013, 8(1):159-173.
    • 19. Harrison R A, et al: Research strategies to improve snakebite treatment: Challenges and progress. Journal of Proteomics 2011, 74(9):1768-1780.
    • 20. Molesworth A M, et al: Geographic information system mapping of snakebite incidence in northern Ghana and Nigeria using environmental indicators: a preliminary study. Transactions of The Royal Society of Tropical Medicine and Hygiene 2003, 97(2):188-192.
    • 21. Smith D L, et al: A sticky situation: the unexpected stability of malaria elimination. Philosophical Transactions of the Royal Society B: Biological Sciences 2013, 368(1623):20120145.
    • 22. Killeen G F, et al: Eradication of Anopheles gambiae from Brazil: lessons for malaria control in Africa? Lancet Infect Dis 2002, 2(10):618-27.
    • 23. Manderson L, et al: Social research on neglected diseases of poverty: continuing and emerging themes. PLoS Negl Trop Dis 2009, 3(2):e332.
    • 24. Kagbadouno M S, et al: Epidemiology of Sleeping Sickness in Boffa (Guinea): Where Are the Trypanosomes? PLoS Negl Trop Dis 2012, 6(12): e1949.
    • 25. Meredith S E, Cross C, Amazigo U V: Empowering communities in combating river blindness and the role of NGOs: case studies from Cameroon, Mali, Nigeria, and Uganda. Health Res Policy Syst 2012, 10:16.
    • 26. Amazigo U, et al: Performance of predictors: evaluating sustainability in community-directed treatment projects of the African programme for onchocerciasis control. Soc Sci Med 2007, 64(10):2070-82.
    • 27. Amazigo U V, et al: Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 2002, 96(Suppl 1): S75-92.
  • No similar publications.